- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips joins forces with Seattle Systems
Philips joins forces with Seattle SystemsPhilips Medical Systems has announced a partnership with clinical information systems developer Seattle Systems. In an effort to provide hospitals with the ability to integrate x-ray images, patient
Philips joins forces with Seattle Systems
Philips Medical Systems has announced a partnership with clinical information systems developer Seattle Systems. In an effort to provide hospitals with the ability to integrate x-ray images, patient monitoring, and other cardiological diagnostic data, Philips will combine its cardiac imaging systems and networks with Seattle Systems' cardiovascular information management systems.
The two companies already support such a system at Virginia Mason Medical Center, a 336-bed hospital in Seattle. Virginia Mason's Heart Center performs more than 2000 diagnostic and 600 interventional procedures a year, and its three catheterization laboratories use the Integris system from Philips. The hospital is also using the company's Inturis for Cardiology system to perform imaging exams online, and has discontinued its use of conventional cine film, according to the Best, Netherlands-based firm.
- Search again
- Homepage
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
